MENU
ACXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more

A.I. Advisor
published Earnings

ACXP is expected to report earnings to rise 63.64% to -18 cents per share on August 12

Acurx Pharmaceuticals ACXP Stock Earnings Reports
Q2'25
Est.
$-0.18
Q1'25
Beat
by $0.27
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.09
The last earnings report on May 13 showed earnings per share of -10 cents, beating the estimate of -37 cents. With 10.71K shares outstanding, the current market capitalization sits at 6.88M.
View a ticker or compare two or three
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACXP showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
259 Liberty Avenue
Phone
+1 917 533-1469
Employees
4
Web
https://www.acurxpharma.com